Evidence map›Paper›PMID 12456890›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis.

Suet Y Leung, Xin Chen, Kent M Chu, Siu T Yuen, Jonathan Mathy, Jiafu Ji, Annie S Y Chan, Rui Li, Simon Law, Olga G Troyanskaya and 5 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 183 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Human Group IIA Secreted Phospholipase AInternational journal of molecular sciences · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Phosphoglucose isomerase gene expression as a prognostic biomarker of gastric cancer.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2019
    Article
  14. Group III phospholipase AScientific reports · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Lipoquality control by phospholipase AProceedings of the Japan Academy. Series B, Physical and biological sciences · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Suet Y LeungDepartments of Pathology and Surgery, University of Hong Kong, Hong Kong, China.
Xin Chen
Kent M Chu
Siu T Yuen
Jonathan Mathy
Jiafu Ji
Annie S Y Chan
Rui Li
Simon Law
Olga G Troyanskaya
I-Ping Tu
John Wong
Samuel So
David Botstein
Patrick O Brown
Peking University · CNUniversity of Hong Kong · HKPeking University Cancer Hospital · CNHoward Hughes Medical Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We analyzed gene expression patterns in human gastric cancers by using cDNA microarrays representing approximately equal 30,300 genes. Expression of PLA2G2A, a gene previously implicated as a modifier of the Apc(Min/+) (multiple intestinal neoplasia 1) mutant phenotype in the mouse, was significantly correlated with patient survival. We confirmed this observation in an independent set of patient samples by using quantitative RT-PCR. Beyond its potential diagnostic and prognostic significance, this result suggests the intriguing possibility that the activity of PLA2G2A may suppress progression or metastasis of human gastric cancer.

Indexed as

AdenocarcinomaDisease ProgressionDNA, ComplementaryEnzyme InductionGastric MucosaGene Expression ProfilingGene Expression Regulation, NeoplasticGroup II Phospholipases A2HumansIn Situ HybridizationLife TablesNeoplasm ProteinsOligonucleotide Array Sequence AnalysisPhospholipases APhospholipases A2PrognosisDNA, ComplementaryGroup II Phospholipases A2Neoplasm ProteinsPhospholipases APhospholipases A2PLA2G2A protein, humanPla2g2a protein, mouse

Identifiers

PMID12456890
PMCPMC138589
OpenAlexW2016513155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.